We are a dedicated team of researchers driven by the mission to revolutionize healthcare through groundbreaking scientific discoveries. Our focus is on the development of innovative monoclonal antibodies, with a special emphasis on targeting ferroptosis a unique form of regulated cell death.

Our solutions are designed for pharmaceutical companies, biotech innovators, and research institutions aiming to advance precision medicine. By exploring the therapeutic potential of rat monoclonal antibodies against ferroptosis, we aim to unlock new treatment strategies for cancer, neurodegenerative diseases, and beyond.

Nehmen Sie Kontakt auf

Kontakt
info@teitell-lab.com
+14087800908

Folgen Sie uns

English (UK) | English (US) | Français (BE) | Deutsch

Powered by

- Die #1 Open-Source-E-Commerce